DIBASE 100.000UI / ml injectible solution medication leaflet

A11CC05 cholecalciferol • Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues

Cholecalciferol, also known as vitamin D3, is a form of vitamin D used for the prevention and treatment of vitamin D deficiency. It is essential for bone health as it aids in the absorption of calcium and phosphorus from food, preventing conditions such as rickets in children and osteomalacia or osteoporosis in adults.

Cholecalciferol is indicated in cases of vitamin D deficiency, for fracture prevention, and in the treatment of hypocalcemia associated with hypoparathyroidism. It is available in capsules, tablets, oral drops, or injectable solutions.

Side effects are rare but may include nausea, constipation, excessive thirst, or hypercalcemia (high calcium levels in the blood) in cases of overdose. It is contraindicated in patients with hypercalcemia, hypervitaminosis D, or severe renal impairment.

General data about DIBASE 100.000UI / ml

Substance: cholecalciferol

Date of last drug list: 01-06-2023

Commercial code: W67598001

Concentration: 100.000UI / ml

Pharmaceutical form: injectible solution

Quantity: 6

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ABIOGEN PHARMA S.P.A. - ITALIA

Holder: IMECO S.A. - ROMANIA

Number: 592/2021/01

Shelf life: 3 years

Pharmaceutical forms available for cholecalciferol

Concentrations available for cholecalciferol

0.45mg/ml, 0.5mg/ml, 100.000UI/ml, 10000UI, 1000UI, 14400UI/ml, 18000UI/ml, 200000UI/ml, 20000UI, 20000UI/ml, 300.000UI/ml, 30000UI, 5000UI, 500UI, 7000UI